Skip to main content
Erschienen in: CardioVascular and Interventional Radiology 4/2013

01.08.2013 | Clinical Investigation

Transjugular Intrahepatic Portosystemic Shunt for Treatment of Cirrhosis-related Chylothorax and Chylous Ascites: Single-institution Retrospective Experience

verfasst von: Steven G. Kikolski, Hamed Aryafar, Steven C. Rose, Anne C. Roberts, Thomas B. Kinney

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the efficacy and safety of the use of transjugular intrahepatic portosystemic shunt (TIPS) creation to treat cirrhosis-related chylous collections (chylothorax and chylous ascites).

Methods

We retrospectively reviewed data from four patients treated for refractory cirrhosis-related chylous collections with TIPS at our institution over an 8 year period.

Results

One patient had chylothorax, and three patients had concomitant chylothorax and chylous ascites. There were no major complications, and the only procedure-related complications occurred in two patients who had mild, treatable hepatic encephalopathy. All patients had improvement as defined by decreased need for thoracentesis or paracentesis, with postprocedure follow-up ranging from 19 to 491 days.

Conclusion

TIPS is a safe procedure that is effective in the treatment of cirrhosis-related chylous collections.
Literatur
1.
Zurück zum Zitat Light RW (2007) Chylothorax and pseudochylothorax. In: Pleural diseases. Lippincott Williams & Wilkins, Philadelphia, pp 346–361 Light RW (2007) Chylothorax and pseudochylothorax. In: Pleural diseases. Lippincott Williams & Wilkins, Philadelphia, pp 346–361
2.
Zurück zum Zitat Romero S, Martín C, Hernandez L et al (1998) Chylothorax in cirrhosis of the liver: analysis of its frequency and clinical characteristics. Chest 114:154–159PubMedCrossRef Romero S, Martín C, Hernandez L et al (1998) Chylothorax in cirrhosis of the liver: analysis of its frequency and clinical characteristics. Chest 114:154–159PubMedCrossRef
3.
Zurück zum Zitat Maldonado F, Hawkins FJ, Daniels CE et al (2009) Pleural fluid characteristics of chylothorax. Mayo Clin Proc 84:129–133PubMedCrossRef Maldonado F, Hawkins FJ, Daniels CE et al (2009) Pleural fluid characteristics of chylothorax. Mayo Clin Proc 84:129–133PubMedCrossRef
4.
Zurück zum Zitat Doerr CH, Allen MS, Nichols FC et al (2005) Etiology of chylothorax in 203 patients. Mayo Clin Proc 80:867–870PubMedCrossRef Doerr CH, Allen MS, Nichols FC et al (2005) Etiology of chylothorax in 203 patients. Mayo Clin Proc 80:867–870PubMedCrossRef
5.
Zurück zum Zitat Staats BA, Ellefson RD, Budahn LL et al (1980) The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc 55:700–704PubMed Staats BA, Ellefson RD, Budahn LL et al (1980) The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc 55:700–704PubMed
6.
Zurück zum Zitat Frick E, Scholmerich J (2005) Etiology, diagnosis, and management of non-cirrhotic ascites. In: Ginès P, Arroyo V, Rodes J, Schrier R (eds) Ascites and renal dysfunction in liver diseases: pathogenesis, diagnosis, and treatment. Blackwell Publishing, Oxford, pp 294–304CrossRef Frick E, Scholmerich J (2005) Etiology, diagnosis, and management of non-cirrhotic ascites. In: Ginès P, Arroyo V, Rodes J, Schrier R (eds) Ascites and renal dysfunction in liver diseases: pathogenesis, diagnosis, and treatment. Blackwell Publishing, Oxford, pp 294–304CrossRef
7.
Zurück zum Zitat Cárdenas A, Chopra S (2002) Chylous ascites. Am J Gastroenterol 97:1896–1900PubMed Cárdenas A, Chopra S (2002) Chylous ascites. Am J Gastroenterol 97:1896–1900PubMed
8.
Zurück zum Zitat Witte CL, Witte MH, Dumont AE (1980) Lymph imbalance in the genesis and perpetuation of the ascites syndrome in hepatic cirrhosis. Gastroenterology 78(5 pt 1):1059–1068PubMed Witte CL, Witte MH, Dumont AE (1980) Lymph imbalance in the genesis and perpetuation of the ascites syndrome in hepatic cirrhosis. Gastroenterology 78(5 pt 1):1059–1068PubMed
9.
Zurück zum Zitat Witte MH, Dumont AE, Cole WR et al (1969) Lymph circulation in hepatic cirrhosis: effect of portacaval shunt. Ann Intern Med 70:303–310PubMedCrossRef Witte MH, Dumont AE, Cole WR et al (1969) Lymph circulation in hepatic cirrhosis: effect of portacaval shunt. Ann Intern Med 70:303–310PubMedCrossRef
10.
Zurück zum Zitat Orloff MJ, Goodhead B, Windsor CW et al (1967) Effect of portacaval shunts on lymph flow in the thoracic duct. Experiments with normal dogs and dogs with cirrhosis and ascites. Am J Surg 114:213–221PubMedCrossRef Orloff MJ, Goodhead B, Windsor CW et al (1967) Effect of portacaval shunts on lymph flow in the thoracic duct. Experiments with normal dogs and dogs with cirrhosis and ascites. Am J Surg 114:213–221PubMedCrossRef
11.
Zurück zum Zitat Dumont AE, Witte MH (1996) Contrasting patterns of thoracic duct lymph formation in hepatic cirrhosis. Surg Gynecol Obstet 122:524–528 Dumont AE, Witte MH (1996) Contrasting patterns of thoracic duct lymph formation in hepatic cirrhosis. Surg Gynecol Obstet 122:524–528
12.
Zurück zum Zitat Dumont AE, Mulholland JH (1962) Alterations in thoracic duct lymph flow in hepatic cirrhosis: significance in portal hypertension. Ann Surg 156:668–675PubMedCrossRef Dumont AE, Mulholland JH (1962) Alterations in thoracic duct lymph flow in hepatic cirrhosis: significance in portal hypertension. Ann Surg 156:668–675PubMedCrossRef
13.
Zurück zum Zitat Dumont AE, Mulholland JH (1960) Flow rate and composition of thoracic-duct lymph in patients with cirrhosis. N Engl J Med 263:471–474PubMedCrossRef Dumont AE, Mulholland JH (1960) Flow rate and composition of thoracic-duct lymph in patients with cirrhosis. N Engl J Med 263:471–474PubMedCrossRef
14.
Zurück zum Zitat Rosser BG, Poterucha JJ, McKusick MA et al (1996) Thoracic duct–cutaneous fistula in a patient with cirrhosis of the liver: successful treatment with a transjugular intrahepatic portosystemic shunt. Mayo Clin Proc 71:793–796PubMedCrossRef Rosser BG, Poterucha JJ, McKusick MA et al (1996) Thoracic duct–cutaneous fistula in a patient with cirrhosis of the liver: successful treatment with a transjugular intrahepatic portosystemic shunt. Mayo Clin Proc 71:793–796PubMedCrossRef
15.
Zurück zum Zitat Vignaux O, Gouya H, Dousset B et al (2002) Refractory chylothorax in hepatic cirrhosis: successful treatment by transjugular intrahepatic portosystemic shunt. J Thorac Imaging 17:233–236PubMedCrossRef Vignaux O, Gouya H, Dousset B et al (2002) Refractory chylothorax in hepatic cirrhosis: successful treatment by transjugular intrahepatic portosystemic shunt. J Thorac Imaging 17:233–236PubMedCrossRef
16.
Zurück zum Zitat de Vries GJ, Ryan BM, de Bièvre M et al (2005) Cirrhosis related chylous ascites successfully treated with TIPS. Eur J Gastroenterol Hepatol 17:463–466PubMedCrossRef de Vries GJ, Ryan BM, de Bièvre M et al (2005) Cirrhosis related chylous ascites successfully treated with TIPS. Eur J Gastroenterol Hepatol 17:463–466PubMedCrossRef
17.
Zurück zum Zitat Kinney TB, Ferrara SL, Miller FJ et al (2004) Transjugular intrahepatic portosystemic shunt creation as treatment for refractory chylous ascites and chylothorax in a patient with cirrhosis. J Vasc Interv Radiol 15(1 pt 1):85–89PubMedCrossRef Kinney TB, Ferrara SL, Miller FJ et al (2004) Transjugular intrahepatic portosystemic shunt creation as treatment for refractory chylous ascites and chylothorax in a patient with cirrhosis. J Vasc Interv Radiol 15(1 pt 1):85–89PubMedCrossRef
18.
Zurück zum Zitat Garcia N, Mihas AA (2004) Hepatic hydrothorax: pathophysiology, diagnosis, and management. J Clin Gastroenterol 38:52–58PubMedCrossRef Garcia N, Mihas AA (2004) Hepatic hydrothorax: pathophysiology, diagnosis, and management. J Clin Gastroenterol 38:52–58PubMedCrossRef
Metadaten
Titel
Transjugular Intrahepatic Portosystemic Shunt for Treatment of Cirrhosis-related Chylothorax and Chylous Ascites: Single-institution Retrospective Experience
verfasst von
Steven G. Kikolski
Hamed Aryafar
Steven C. Rose
Anne C. Roberts
Thomas B. Kinney
Publikationsdatum
01.08.2013
Verlag
Springer New York
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 4/2013
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-012-0530-x

Weitere Artikel der Ausgabe 4/2013

CardioVascular and Interventional Radiology 4/2013 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.